Tenaya Therapeutics (TNYA) Revenue & Revenue Breakdown
Tenaya Therapeutics Revenue Highlights
Tenaya Therapeutics Revenue by Period
Tenaya Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Tenaya Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Tenaya Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $17.66M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Tenaya Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tenaya Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OCUL | Ocular Therapeutix | $58.44M | $14.71M |
| BCYC | Bicycle Therapeutics | $26.98M | $9.36M |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| IGMS | IGM Biosciences | $2.13M | $497.00K |
| FIXX | Q32 Bio | $1.16M | - |
| EYEN | Eyenovia | $3.79K | $4.99K |
| CRVS | Corvus Pharmaceuticals | - | - |
| ALXO | ALX Oncology | - | - |
| GOSS | Gossamer Bio | - | $95.84M |
| INZY | Inozyme Pharma | - | - |
| DRTS | Alpha Tau Medical | - | - |
| BMEA | Biomea Fusion | - | - |
| VINC | Vincerx Pharma | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| AKRO | Akero Therapeutics | - | - |
| TNYA | Tenaya Therapeutics | - | - |
| RANI | Rani Therapeutics | - | - |
TNYA Revenue FAQ
What is Tenaya Therapeutics’s yearly revenue?
Tenaya Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TNYA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Tenaya Therapeutics’s quarterly revenue?
Tenaya Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TNYA's quarterly revenue for Q4 2023 was $17.66M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Tenaya Therapeutics’s revenue growth rate?
Tenaya Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.